Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate
(217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- Isotope Science and Enrichment Directorate (6)
- National Security Sciences Directorate (17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
Researcher
- Yaosuo Xue
- Alexander I Kolesnikov
- Alexei P Sokolov
- Bekki Mills
- Bruce Moyer
- Debjani Pal
- Fei Wang
- Jeffrey Einkauf
- Jennifer M Pyles
- John Wenzel
- Justin Griswold
- Keju An
- Kuntal De
- Laetitia H Delmau
- Luke Sadergaski
- Mark Loguillo
- Matthew B Stone
- Mike Zach
- Padhraic L Mulligan
- Phani Ratna Vanamali Marthi
- Rafal Wojda
- Sandra Davern
- Shannon M Mahurin
- Sreenivasa Jaldanki
- Suman Debnath
- Sunil Subedi
- Tao Hong
- Tomonori Saito
- Victor Fanelli
- Yonghao Gui

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

Neutron scattering experiments cover a large temperature range in which experimenters want to test their samples.

Measurements of grid voltage and current are essential for the optimal operation of the grid protection and control (P&C) systems.

Neutron beams are used around the world to study materials for various purposes.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

Multi-terminal DC (MTdc) systems based on high-voltage DC (HVDC) transmission technology is an upcoming concept. In such systems, either asymmetric monopole or bi-pole systems are generally employed. Such systems are not suitable for easy expansion.

Stability performance of interconnected power grids plays crucial roles on their secure operation to prevent cascading failure and blackout.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.